Author: Thuy Larsen

There is a clear description in GCP regarding requirement for accountability of investigational medicinal products such as: 4.6.1: Responsibility for investigational product(s) accountability at the trial site(s) rests with the investigator/institution. 4.6.3 The investigator/institution and/or a pharmacist or other appropriate individual, who is designated by the investigator/institution,...

Albert Einstein:
Success = Work + Play
Successful business = Knowledge + Quality
Get in touch with us
We work closely with you and carry out research to understand your needs and wishes.